Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Varenicline Tartrate Controlled Release
Varenicline Controlled Release · 1 trial · 3 indications
| Arm | Type | Description |
|---|---|---|
| Varenicline Controlled Release, Fasted | EXPERIMENTAL | - |
| Varenicline Controlled Release, Fed | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Varenicline Tartrate Controlled Release | DRUG | A single, 2.4 mg dose of a varenicline controlled release tablet administered orally under fasted conditions |
Inclusion Criteria: * Healthy male or female adult smokers * 18 to 55 years of age Exclusion Criteria: * Sensitivity to varenicline * Illegal drug use * Pregnant or nursing females
Varenicline Controlled Release is an investigational small molecule being developed by Pfizer, Inc. (PFE) for smoking cessation. It is a controlled release formulation of varenicline tartrate, also known as Varenicline Tartrate Controlled Release. The drug is in Phase 1 clinical development.
Varenicline Controlled Release is being developed for smoking cessation. It is intended to help people quit smoking. The drug is in Phase 1 testing and has not been approved for any indication.
Varenicline Controlled Release targets CHRNB2 and CHRNA4. It acts as an agonist at these targets. This mechanism is associated with its development for smoking cessation.
Pfizer, Inc. (ticker: PFE) is developing Varenicline Controlled Release. Pfizer is the company responsible for the clinical development of this controlled release formulation of varenicline tartrate.
Varenicline Controlled Release is in Phase 1 clinical development. It is an investigational drug and has not been approved by the FDA. The only completed trial was a Phase 1 study.
Varenicline Controlled Release has been studied in one completed Phase 1 trial, NCT00731562, titled "An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation." The trial enrolled 24 healthy volunteers in the United States and is now completed.
Yes, Varenicline Controlled Release is also known as Varenicline Tartrate Controlled Release. Both names refer to the same investigational drug being developed by Pfizer for smoking cessation.